US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emera Inc.

46.69

+0.05000.11%

Volume:11.25K

Turnover:524.78K

Market Cap:13.91B

PE:22.57

High:46.71

Open:46.44

Low:46.42

Close:46.64

Loading ...

Overview Company News Filings

Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy

Flare (FLR) Jumps 15% as Volume Soars—Is a Major Rally Brewing?

Pi Coin Teases a Quick 40% Burst If This One EMA Cross Confirms

Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis

3 CoinGecko Top Gainers to Watch for the Fourth Week of July

Bank of America Securities Reaffirms Their Buy Rating on Emera (EMA)

Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110

Shiba Inu (SHIB): Fundamental Shift, XRP Sky Is Not Limit Now, Bitcoin (BTC) Price Cools Down

HBAR Price Rallies 20% After $230 Million Inflow from Traders in a Week

Zevra Therapeutics Announces MIPLYFFA® and OLPRUVA® Presentations at the Annual Meeting of the Southeastern Regional Genetics Group (SERGG)

BMO Capital Sticks to Its Buy Rating for Emera (EMA)

Press Release: Emera Incorporated Announces Dividend Rates for Series A and Series B First Preferred Shares

Zevra Therapeutics Announces Open Label Extension Data Showing Sustained Long-Term Efficacy of MIPLYFFA for the Treatment of NPC Published in the Journal of Molecular Genetics and Metabolism

Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film

Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)

Valneva’s Chikungunya Vaccine Restriction Lifted by EMA

Ethena (ENA) Hits 30-Day High as Spot and Futures Demand Surge

Zevra Therapeutics Announces MIPLYFFA® (arimoclomol) Featured in Presentations at the National Niemann Pick Disease Foundation Conference

Press Release: Emera Declares Quarterly Dividends

Cardano Shorts' Bloodbath Triggers 4,146% Liquidation Imbalance in One Hour

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EMA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMA\",,,,,undefined,":{"symbol":"EMA","market":"US","secType":"STK","nameCN":"Emera Inc.","latestPrice":46.69,"timestamp":1753370696186,"preClose":46.64,"halted":0,"volume":11252,"delay":0,"floatShares":297632664,"shares":297900000,"eps":2.069006,"marketStatus":"Trading","change":0.05,"latestTime":"07-24 11:25:47 EDT","open":46.44,"high":46.71,"low":46.42,"amount":524780.3402,"amplitude":0.006218,"askPrice":46.85,"askSize":200,"bidPrice":46.65,"bidSize":300,"shortable":3,"etf":0,"ttmEps":2.069006,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1753387200000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":46.64,"dividendRate":0.045393,"postHourTrading":{"tag":"盘后","latestPrice":46.64,"preClose":46.64,"latestTime":"16:45 EDT","volume":18040,"amount":840377.104722,"timestamp":1753303551959},"volumeRatio":0.418787,"impliedVol":0,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMA\",,,,,undefined,":{"symbol":"EMA","floatShares":297632664,"roa":"2.73%","roe":"7.21%","lyrEps":1.186627,"volumeRatio":0.418787,"shares":297900000,"dividePrice":2.116675,"high":46.71,"amplitude":0.006218,"preClose":46.64,"low":46.42,"week52Low":43.9012,"pbRate":"1.54","psRate":"2.41","week52High":47.05,"institutionHeld":0,"latestPrice":46.69,"committee":0.2,"eps":2.069006,"divideRate":0.045335,"volume":11252,"delay":0,"ttmEps":2.069006,"open":46.44,"prevYearClose":45.28,"prevWeekClose":45.66,"prevMonthClose":45.82,"prevQuarterClose":45.82,"fiveDayClose":45.14,"twentyDayClose":44.85,"earningDate":1754582400000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EMA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553788259","title":"Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy","url":"https://stock-news.laohu8.com/highlight/detail?id=2553788259","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553788259?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:00","pubTimestamp":1753354800,"startTime":"0","endTime":"0","summary":"Expedited Enrollment Surpassing 630 Targeted Participants Underscores the Strong Demand for a Therapy Focused on Vision Preservation Phase 3 ARCHER II Trial Design and Rationale to Be Presented at ASR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/24/3120898/0/en/Annexon-Announces-Completion-of-Enrollment-in-Pivotal-Phase-3-ARCHER-II-Trial-of-Vonaprument-formerly-ANX007-for-Dry-Age-Related-Macular-Degeneration-AMD-with-Geographic-Atrophy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1852331112.SGD","LU0127658192.USD","LU1951200564.SGD","BK4081","LU1303367103.USD","IE0004445239.USD","LU2458330169.SGD","LU0109392836.USD","IE0009356076.USD","BK4575","BK4614","LU0823434740.USD","IE00BMPRXR70.SGD","PT","BK4573","LU1880398554.USD","EMA","LU1242518931.SGD","LU0823421333.USD","LU2264538146.SGD","GFS","LU0719512351.SGD","LU0823421416.USD","BK4107","IE00B5949003.HKD","FAF","BK4554","BK4534","LU2098885051.SGD","LU0390134368.USD","LU0823434583.USD","BK4529","LU0198837287.USD","BK4532","LU0979878070.USD","ANNX","LU1988902786.USD","BK4612","BK4141","LU1951198990.SGD","LU2054465674.USD","BK4566","LU1989764664.SGD","LU2458330243.SGD","LU1064131342.USD","LU0889565833.HKD","BK4543","LU1923623000.USD","LU0082616367.USD"],"gpt_icon":1},{"id":"2553466492","title":"Flare (FLR) Jumps 15% as Volume Soars—Is a Major Rally Brewing?","url":"https://stock-news.laohu8.com/highlight/detail?id=2553466492","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553466492?lang=en_us&edition=fundamental","pubTime":"2025-07-23 20:30","pubTimestamp":1753273800,"startTime":"0","endTime":"0","summary":"Flare  surges 15% in 24 hours, outperforming many assets, signaling strong market optimism.FLR's trading volume jumps 300%, reaching $70.41 million—its highest since December 2024.FLR trades above its 20-day EMA, indicating short-term bullish momentum with potential for further upside.As the broader crypto market recovers from yesterday’s pullback, Layer 1  coin Flare  emerges as one of the strongest performers.The token has gained over 15% in the past 24 hours, outperforming many assets and signaling renewed optimism among traders.FLR’s trading volume has skyrocketed by over 300% over the past day. This points to heightened demand and confirms the wave of bullish momentum currently driving its price action.As of this writing, the volume totals $70.41 million, marking its highest single-day trading activity since December 3, 2024.However, any spike in profit-taking could invalidate this bullish setup. A rejection at current levels might send the price back to $0.02144, a critical suppo","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2025/06/altcoin-season-2025-delayed-850x478.png","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2025/06/altcoin-season-2025-delayed-850x478.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/flr-price-breaks-out-bullish-momentum/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4129","EMA","FLR","BK4081"],"gpt_icon":0},{"id":"2553055292","title":"Pi Coin Teases a Quick 40% Burst If This One EMA Cross Confirms","url":"https://stock-news.laohu8.com/highlight/detail?id=2553055292","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553055292?lang=en_us&edition=fundamental","pubTime":"2025-07-23 14:30","pubTimestamp":1753252200,"startTime":"0","endTime":"0","summary":"ADX back above 30 shows real trend strength, but a higher print is needed.One EMA cross is done; a second, uncompleted cross could unlock the next leg.Key caps sit at $0.49–$0.51; clearing the same could reopen $0.66 .Pi Coin is steady around $0.47 after the “Buy Pi” fiat onramp announcement kicked price up to $0.52; the first real push in days.Two technical signals on the lower timeframe hint this may not be a one-off bounce: trend strength is back, and a second movingaverage trigger is close.The fast  Exponential Moving Average  has already crossed above the medium  EMA, and that lined up with the move from $0.45 to $0.52.Pi Coin price and EMA crossover : TradingView. The 200period EMA  on the 4hour chart was briefly crossed by the price yesterday, before experiencing resistance. A clean close above it would match the price structure with momentum.A daily close above that range opens $0.54 first  and then $0.66, the prior swing high, roughly 40% above current levels if momentum carri","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2025/03/bic_Pi_network_1-covers_bullish-850x478.jpg.optimal.jpg","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2025/03/bic_Pi_network_1-covers_bullish-850x478.jpg.optimal.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/pi-coin-price-40-percent-burst-ema-cross/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4081","ADX","EMA"],"gpt_icon":0},{"id":"2553263028","title":"Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2553263028","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553263028?lang=en_us&edition=fundamental","pubTime":"2025-07-23 04:05","pubTimestamp":1753214700,"startTime":"0","endTime":"0","summary":"Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/22/3119843/0/en/Abivax-Announces-Positive-Phase-3-Results-from-Both-ABTECT-8-Week-Induction-Trials-Investigating-Obefazimod-its-First-in-Class-Oral-miR-124-Enhancer-in-Moderate-to-Severely-Active-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA","BK4081"],"gpt_icon":0},{"id":"2553940972","title":"3 CoinGecko Top Gainers to Watch for the Fourth Week of July","url":"https://stock-news.laohu8.com/highlight/detail?id=2553940972","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553940972?lang=en_us&edition=fundamental","pubTime":"2025-07-22 03:04","pubTimestamp":1753124640,"startTime":"0","endTime":"0","summary":"Mango Network  rose 128%, crossing above its 20-day EMA and forming bullish support; the next key target is $0.029.ZORA gains 90% as trading volume surges 293%, signaling strong momentum and setting up for a potential push to $0.025.The past week has seen a notable surge in crypto trading activity, fueled by improving market sentiment and investor confidence. This uptick is reflected in the 3% increase in the global crypto market capitalization over the last seven days.As attention returns to altcoins, several lesser-known tokens have emerged as standout performers. According to Coingecko’s data, here are three top gainers to keep an eye on for the third week of July:. Over the past 24 hours, ZORA has noted 40% gains. During the review period, the token’s trading volume surged by 293%, reaching $161.17 million. The increase in the token’s price and trading volume indicates strong bullish momentum and heightened investor interest.","market":"nz","thumbnail":"https://beincrypto.com/wp-content/uploads/2025/07/altcoin-season-july-850x478.png","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2025/07/altcoin-season-july-850x478.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/coingecko-top-crypto-gainers-july/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4081","EMA"],"gpt_icon":0},{"id":"2553777934","title":"Bank of America Securities Reaffirms Their Buy Rating on Emera (EMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2553777934","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553777934?lang=en_us&edition=fundamental","pubTime":"2025-07-21 21:46","pubTimestamp":1753105577,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Ross Fowler maintained a Buy rating on Emera today. The company’s shares opened today at $45.75. Fowler covers t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-reaffirms-their-buy-rating-on-emera-ema-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-reaffirms-their-buy-rating-on-emera-ema-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EMA","BAC"],"gpt_icon":0},{"id":"2553265471","title":"Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110","url":"https://stock-news.laohu8.com/highlight/detail?id=2553265471","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553265471?lang=en_us&edition=fundamental","pubTime":"2025-07-21 20:00","pubTimestamp":1753099200,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., July  21, 2025  (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/21/3118672/0/en/Korro-Receives-European-Medicines-Agency-Orphan-Drug-Designation-for-KRRO-110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4505","MDCO","RNA","BK4139","EMA","BK4081","KRRO","BK4585"],"gpt_icon":0},{"id":"2553405145","title":"Shiba Inu (SHIB): Fundamental Shift, XRP Sky Is Not Limit Now, Bitcoin (BTC) Price Cools Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2553405145","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553405145?lang=en_us&edition=fundamental","pubTime":"2025-07-21 00:01","pubTimestamp":1753027260,"startTime":"0","endTime":"0","summary":"Recently Shiba Inu made a clean break above the 200-day exponential moving average (EMA), one of its most structurally significant technical moves in months. This could be a change in the asset's whol","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/shiba-inu-shib-fundamental-shift-xrp-sky-is-not-limit-now-bitcoin-btc-price-cools-down","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["BTC.USD.HKCC","BTCmain","BTC.AU","MBTmain","09008","BTC","BTC.USD.CC","09042","BK4081","BK4585","09439","EMA","XBTmain","03008","BK4594","03042","83042","03439","BK1611","BK4601","BK4588"],"gpt_icon":1},{"id":"2552499745","title":"HBAR Price Rallies 20% After $230 Million Inflow from Traders in a Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2552499745","media":"BE[IN]CRYPTO","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552499745?lang=en_us&edition=fundamental","pubTime":"2025-07-18 21:00","pubTimestamp":1752843600,"startTime":"0","endTime":"0","summary":"HBAR has surged by 20% in the last 24 hours, reaching a 5-month high, driven by a $230 million increase in open interest and rising trader confidence.The Golden Cross between HBAR’s 50-day and 200-day EMAs signals a shift from bearish to bullish momentum, supporting further price gains.HBAR is holding a critical support level at $0.267, and a push above $0.314 could lead to a rise toward $0.375. However, profit-taking risks remain, with a drop to $0.241 possible.HBAR, the native cryptocurrency of the Hedera network, has experienced a significant 20% price jump over the last 24 hours, reaching a 5-month high.This surge in value comes after a period of sustained growth, driven by both positive market sentiment and increased activity in the derivatives market.However, the risk of selling remains. Should HBAR experience a wave of profit-taking from investors, the price could fall back","market":"fut","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/04/bic_Hedera_HBAR_3-covers_neutral-850x478.jpg.optimal.jpg","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/04/bic_Hedera_HBAR_3-covers_neutral-850x478.jpg.optimal.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/hbar-price-rallies-after-inflow-from-trader/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["OI","EMA","BK4126","BK4081"],"gpt_icon":0},{"id":"2552012462","title":"Zevra Therapeutics Announces MIPLYFFA® and OLPRUVA® Presentations at the Annual Meeting of the Southeastern Regional Genetics Group (SERGG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2552012462","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552012462?lang=en_us&edition=fundamental","pubTime":"2025-07-18 19:30","pubTimestamp":1752838200,"startTime":"0","endTime":"0","summary":"CELEBRATION, Fla., July  18, 2025  (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living wi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/18/3117839/16626/en/Zevra-Therapeutics-Announces-MIPLYFFA-and-OLPRUVA-Presentations-at-the-Annual-Meeting-of-the-Southeastern-Regional-Genetics-Group-SERGG.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4124","BSA","CPS","ZVRA","BK4007","EMA","BK4202","AS","BK4081"],"gpt_icon":0},{"id":"2552457753","title":"BMO Capital Sticks to Its Buy Rating for Emera (EMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2552457753","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552457753?lang=en_us&edition=fundamental","pubTime":"2025-07-18 15:05","pubTimestamp":1752822309,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Benjamin Pham from BMO Capital reiterated a Buy rating on Emera, with a price target of C$65.00. The company’s shar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bmo-capital-sticks-to-its-buy-rating-for-emera-ema-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bmo-capital-sticks-to-its-buy-rating-for-emera-ema-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EMA","BMO"],"gpt_icon":0},{"id":"2552812759","title":"Press Release: Emera Incorporated Announces Dividend Rates for Series A and Series B First Preferred Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2552812759","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552812759?lang=en_us&edition=fundamental","pubTime":"2025-07-17 01:15","pubTimestamp":1752686100,"startTime":"0","endTime":"0","summary":"Emera Incorporated   announced today the applicable dividend rates for its Cumulative Rate Reset First Preferred Shares, Series A  and Cumulative Floating Rate First Preferred Shares, Series B , in each case, payable if, as and when declared by the Board of Directors of the Company:. quarter), being equal to the sum of the Government of Canada bond yield. as at July 16, 2025, plus 1.84%, payable quarterly on the 15th of. February, May, August and November of each year during the five-year. period commencing on August 15, 2025 and ending on . The conversion of Series A Shares is subject to the conditions that:  if the Company determines, after having taken into account all shares tendered for conversion by holders of Series A Shares that there would remain outstanding on the Conversion Date less than 1,000,000 Series A Shares, all remaining Series A Shares will automatically be converted into Series B Shares on a one-for-one basis on the Conversion Date, and  alternatively, if the Compa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","EMA"],"gpt_icon":0},{"id":"2551140383","title":"Zevra Therapeutics Announces Open Label Extension Data Showing Sustained Long-Term Efficacy of MIPLYFFA for the Treatment of NPC Published in the Journal of Molecular Genetics and Metabolism","url":"https://stock-news.laohu8.com/highlight/detail?id=2551140383","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551140383?lang=en_us&edition=fundamental","pubTime":"2025-07-16 19:30","pubTimestamp":1752665400,"startTime":"0","endTime":"0","summary":"CELEBRATION, Fla., July  16, 2025  (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living wi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/16/3116288/16626/en/Zevra-Therapeutics-Announces-Open-Label-Extension-Data-Showing-Sustained-Long-Term-Efficacy-of-MIPLYFFA-for-the-Treatment-of-NPC-Published-in-the-Journal-of-Molecular-Genetics-and-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","ZVRA","EMA","BK4007"],"gpt_icon":0},{"id":"2551169711","title":"Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film","url":"https://stock-news.laohu8.com/highlight/detail?id=2551169711","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551169711?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:00","pubTimestamp":1752577200,"startTime":"0","endTime":"0","summary":"New Drug Submission meeting scheduled with Health Canada for the third quarter of 2025Initial briefing book submitted for review to the European Medicines Agency WARREN, N.J., July  15, 2025  (GLOBE N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/15/3115450/0/en/Aquestive-Therapeutics-Provides-International-Expansion-Update-for-Anaphylm-epinephrine-Sublingual-Film.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4588","BK4139","BK4585","MAA","AQST","BK4215","EMA","BK4007","BK4081"],"gpt_icon":0},{"id":"2551931189","title":"Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in  Familial Adenomatous Polyposis (FAP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2551931189","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551931189?lang=en_us&edition=fundamental","pubTime":"2025-07-14 20:30","pubTimestamp":1752496200,"startTime":"0","endTime":"0","summary":"July 14, 2025 Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in  Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/14/3114750/0/en/Biodexa-Announces-Filing-of-CTA-in-Europe-for-Phase-3-Serenta-Trial-in-Familial-Adenomatous-Polyposis-FAP.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","EMA","BK4139","CTA","BDRX"],"gpt_icon":0},{"id":"2550965124","title":"Valneva’s Chikungunya Vaccine Restriction Lifted by EMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2550965124","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550965124?lang=en_us&edition=fundamental","pubTime":"2025-07-12 02:28","pubTimestamp":1752258488,"startTime":"0","endTime":"0","summary":"Valneva ( ($VALN) ) just unveiled an update. On July 11, 2025, Valneva announced that the European Medicines Agency (EMA) lifted the temporary rest...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/valnevas-chikungunya-vaccine-restriction-lifted-by-ema?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/valnevas-chikungunya-vaccine-restriction-lifted-by-ema?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EMA","BK4081"],"gpt_icon":0},{"id":"2550378959","title":"Ethena (ENA) Hits 30-Day High as Spot and Futures Demand Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2550378959","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550378959?lang=en_us&edition=fundamental","pubTime":"2025-07-11 20:00","pubTimestamp":1752235200,"startTime":"0","endTime":"0","summary":"Bitcoin’s all-time high fuels altcoin rally, with Ethena’s ENA surging 25% in 24 hours, making it the top gainer.Spot inflows into ENA reached $3.46 million, the highest in two months, reflecting growing investor confidence.ENA’s futures open interest surged 8%, signaling bullish sentiment and positioning for further price increases.Bitcoin’s explosive rally to a new all-time high above $117,000 has triggered a market-wide resurgence in trading activity, lifting altcoins.One of the biggest beneficiaries of this bullish wave is Ethena’s native token ENA, which has surged 25% in the past 24 hours. This makes it the top gainer in the market today.ENA Leads the Charge as Spot Demand and Derivatives Activity Explode. Now trading at its highest level in 30 days, ENA’s rally comes with a significant spike in investor interest. Spot inflows into the altcoin have surged to a two-month high, signaling a rapid increase in demand from traders looking to ride the bullish momentum of the past 24 hou","market":"fut","thumbnail":"https://beincrypto.com/wp-content/uploads/2025/05/bic_altcoin_coin_1-covers_bullish-850x478.jpg.optimal.jpg","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2025/05/bic_altcoin_coin_1-covers_bullish-850x478.jpg.optimal.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/ena-price-rockets-as-bitcoin-rallies/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["EMA","BTC.USD.HKCC","BTC.USD.CC","BK4081"],"gpt_icon":0},{"id":"2550958304","title":"Zevra Therapeutics Announces MIPLYFFA® (arimoclomol) Featured in Presentations at the National Niemann Pick Disease Foundation Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2550958304","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550958304?lang=en_us&edition=fundamental","pubTime":"2025-07-11 19:30","pubTimestamp":1752233400,"startTime":"0","endTime":"0","summary":"CELEBRATION, Fla., July  11, 2025  (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living wi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/11/3113931/16626/en/Zevra-Therapeutics-Announces-MIPLYFFA-arimoclomol-Featured-in-Presentations-at-the-National-Niemann-Pick-Disease-Foundation-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVRA","BK4007","EMA","BK4081","NHLD"],"gpt_icon":0},{"id":"2550738931","title":"Press Release: Emera Declares Quarterly Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2550738931","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550738931?lang=en_us&edition=fundamental","pubTime":"2025-07-11 18:00","pubTimestamp":1752228000,"startTime":"0","endTime":"0","summary":"On July 11, 2025, the Board of Directors of Emera Inc.  declared quarterly dividends on its common shares and First Preferred Shares, each of which is payable on and after August 15, 2025 to the applicable shareholders of record at the close of business on August 1, 2025, as follows:. This news release contains forward-looking information within the meaning of applicable securities laws, including without limitation, statements about Emera's quarterly dividends. By its nature, forward-looking information requires Emera to make assumptions and is subject to inherent risks and uncertainties. These statements reflect Emera management's current beliefs and are based on information currently available to Emera management. There is a risk that predictions, forecasts, conclusions and projections that constitute forward-looking information will not prove to be accurate, that Emera's assumptions may not be correct and that actual results may differ materially from such forward-looking informati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4081","EMA"],"gpt_icon":0},{"id":"2550399441","title":"Cardano Shorts' Bloodbath Triggers 4,146% Liquidation Imbalance in One Hour","url":"https://stock-news.laohu8.com/highlight/detail?id=2550399441","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550399441?lang=en_us&edition=fundamental","pubTime":"2025-07-11 12:15","pubTimestamp":1752207300,"startTime":"0","endTime":"0","summary":"Cardano (ADA) has joined the ongoing cryptocurrency rally as the price spiked by over 15% in the last 24 hours. This has triggered a staggering 4,146% liquidation imbalance in one hour as short positi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/cardano-shorts-bloodbath-triggers-4146-liquidation-imbalance-in-one-hour","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["BK4162","ATH","BK7016","EMA","BTC.USD.HKCC","BK4081","BK7067","BTC.USD.CC","ATH.AU","ADA.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":73,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EMA\",params:#limit:5,,,undefined,":[{"date":"2025-08-08","symbol":"EMA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":null,"defaultRemindTime":1754640000000,"name":null,"time":"Pre-Market","dateTimestamp":1754625600000,"actualEps":null},{"date":"2025-08-01","symbol":"EMA","amount":0.725,"announcedDate":"2025-07-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-01","defaultRemindTime":1754055000000,"name":"Emera Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-15","payableDate":"2025-08-01","currency":"CAD","dateTimestamp":1754020800000,"payDate":"2025-08-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EMA\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-29","recordDate":"2015-07-31","paymentDate":"2015-08-17","value":0.305564,"currency":"USD"},{"executeDate":"2015-10-29","recordDate":"2015-11-02","paymentDate":"2015-11-16","value":0.3565682,"currency":"USD"},{"executeDate":"2016-01-29","recordDate":"2016-02-02","paymentDate":"2016-02-16","value":0.3421147,"currency":"USD"},{"executeDate":"2016-04-28","recordDate":"2016-05-02","paymentDate":"2016-05-16","value":0.3682105,"currency":"USD"},{"executeDate":"2016-07-20","recordDate":"2016-07-22","paymentDate":"2016-08-15","value":0.4045038,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0667,"buy":0.4,"hold":0.4667,"sell":0,"strongSell":0.0667,"meanLabel":"HOLD","meanPercent":0.4667,"analysts":15,"updateTime":1750996800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EMA","date":"2025-07-22","current":19.990575,"percent":1,"low":19.106036,"twenty":19.308216,"median":19.5641,"eighty":19.731531,"high":19.990575,"avg":19.530931,"sd":0.235915,"marketCap":13828371062.63},"quantilePoints":[{"date":"2025-05-30","current":19.76944,"twenty":19.76944,"median":19.76944,"eighty":19.76944,"marketCap":13505496352.43},{"date":"2025-06-06","current":19.324012,"twenty":19.535669,"median":19.692043,"eighty":19.76944,"marketCap":13350532994.37},{"date":"2025-06-13","current":19.308216,"twenty":19.137627,"median":19.324012,"eighty":19.722054,"marketCap":13371262392.6},{"date":"2025-06-20","current":19.245035,"twenty":19.160372,"median":19.387193,"eighty":19.674036,"marketCap":13211518175.96},{"date":"2025-06-27","current":19.308216,"twenty":19.224185,"median":19.382455,"eighty":19.560942,"marketCap":13348226238.04},{"date":"2025-07-03","current":19.469329,"twenty":19.242508,"median":19.399829,"eighty":19.679723,"marketCap":13533023992.92},{"date":"2025-07-11","current":19.753645,"twenty":19.282944,"median":19.43142,"eighty":19.706259,"marketCap":13611556279.78},{"date":"2025-07-18","current":19.592532,"twenty":19.308216,"median":19.502499,"eighty":19.712577,"marketCap":13439260670.95},{"date":"2025-07-22","current":19.990575,"twenty":19.308216,"median":19.5641,"eighty":19.731531,"marketCap":13828371062.63}],"updateTime":1753340070798}}}